BeiGene Ltd (HK:6160) has released an update.
BeiGene Ltd is set to change its Nasdaq ticker symbol from ‘BGNE’ to ‘ONC’ starting January 2, 2025, as part of its focus on innovative oncology treatments. This change highlights the company’s commitment to advancing global cancer care while maintaining its existing stock codes in Hong Kong and Shanghai.
For further insights into HK:6160 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com